1. What Product Liability Requires to Prove and Which Defect Theory Applies
The choice of defect theory determines what the plaintiff must prove, what the defendant can argue in response, and which facts are most important to develop in discovery.
A manufacturing defect claim is the simplest of the three theories: the plaintiff argues that the specific product that caused the injury deviated from the manufacturer's own design specifications. A car with a brake component that was installed incorrectly at the factory, a medication whose batch contains an incorrect ingredient concentration, and a power tool with a weld that did not meet the manufacturer's own quality control standard each present manufacturing defect claims. The defendant's own design and quality control records become the key evidence, because the standard for liability is whether the product conformed to its intended design, not whether the intended design was safe.
A design defect claim attacks the entire product line rather than a single unit. Every product built to the same design shares the same defect, and the claim is that the design choice itself made the product unreasonably dangerous. The plaintiff must establish that a reasonable alternative design existed that would have reduced or eliminated the risk, at a cost that was economically feasible and without substantially impairing the product's utility. This risk-utility analysis under the Restatement (Third) requires expert testimony about alternative designs, cost of implementation, and the magnitude of risk the current design creates. The consumer expectation test, preserved in some states as an alternative standard, asks simply whether the product performed as safely as an ordinary consumer would expect, without requiring proof of an alternative design. Product liability standards vary significantly by state, particularly on design defect tests, seller liability protections, statutes of repose, and punitive damages limits, which is why the jurisdiction where the case is filed affects which theories are available and how strong each one is.
How Failure to Warn Claims Work and When Warnings Are Insufficient
A failure to warn claim does not require the product to be physically defective. It requires that the product's known risks were not adequately communicated to the users who needed to know them.
Warnings must be adequate in content, placement, and prominence. A warning buried in a multi-page instruction manual, printed in small font, and placed after pages of setup instructions has not effectively communicated a risk that exists at the product's initial use. A warning that identifies a general category of risk without specifying the mechanism, the conditions that trigger it, or the severity of the potential harm may satisfy the letter of the warning requirement while failing the standard of adequacy that plaintiffs argue and juries evaluate. The adequacy question is inherently fact-specific, and the manufacturer's own internal documents about what risks were known, when they were known, and what warnings were considered and rejected are the most valuable discovery materials in failure to warn cases.
Sophisticated user and learned intermediary defenses apply in specific contexts. A pharmaceutical manufacturer's duty to warn runs to the prescribing physician, not directly to the patient, under the learned intermediary doctrine adopted in most states. A manufacturer of industrial equipment sold to sophisticated commercial buyers may argue that detailed technical warnings were not required for a product sold to professionals who are expected to understand its risks from training and experience. These defenses reduce or eliminate the warning obligation in cases where the intermediary or the user's professional knowledge substitutes for direct manufacturer communication with the ultimate user.
| Defect Theory | What Must Be Proved | Key Evidence | Manufacturer Defense |
|---|---|---|---|
| Manufacturing defect | Specific product deviated from design specification | Quality control records, product testing, batch records | Product conformed to specifications |
| Design defect | Entire product line is unreasonably dangerous; safer alternative design existed | Expert testimony on alternative designs, cost-benefit analysis | No reasonable alternative design; risk-utility balance favors design |
| Warning defect | Known risk not adequately communicated to foreseeable users | Internal risk documents, prior incident reports, warning text and placement | Warning was adequate; sophisticated user; learned intermediary |
2. Who Can Be Held Liable for a Defective Product and How Strict Liability Moves through the Supply Chain
Strict product liability under Restatement § 402A extends to every member of the commercial supply chain who placed the product in the stream of commerce, not just the manufacturer who made it.
A manufacturer of the finished product, a manufacturer of a component part incorporated into the finished product, a distributor who purchased the product for resale, and a retailer who sold the product to the consumer each face potential liability for a product defect even though they may have had no role in creating it. The distributor who never opened the product's packaging and the retailer who simply placed it on a shelf are both members of the commercial distribution chain that strict liability reaches. This matters practically when the manufacturer is foreign and difficult to sue, when the manufacturer has dissolved or entered bankruptcy, or when establishing exactly who manufactured a specific component is difficult.
The rationale for extending liability through the supply chain is that companies in the business of distributing and selling products are best positioned to exert pressure on manufacturers to make safe products, to spread the cost of injuries through insurance and pricing, and to bear the cost of harms that result from the products they profit from distributing. A retailer who cannot recover from the manufacturer in indemnification can seek contribution, and the allocation of liability among chain members is typically resolved in third-party claims rather than in the plaintiff's original case. Product liability and mass torts and defective products practice requires identifying all potential defendants at the outset of the case, because statute of limitations issues and bankruptcy filings can foreclose claims against individual chain members if they are not named promptly.
How Pharmaceutical and Medical Device Product Liability Works Differently from Standard Claims
Pharmaceutical drugs and medical devices are subject to FDA regulatory oversight that creates a preemption defense unavailable in standard product cases, and the learned intermediary doctrine shifts the warning obligation away from the manufacturer in ways that require a specific litigation strategy.
Drug manufacturers are required to update their labeling when new safety information becomes available, and the FDA's approval of a drug's labeling does not automatically preempt state law failure to warn claims. The Supreme Court held in Wyeth v. Levine that a state law tort claim for failure to warn against a drug manufacturer was not preempted by FDA approval because the manufacturer had an independent duty under FDA regulations to update its label when it learned of new safety information. Generic drug cases require separate analysis because PLIVA v. Mensing held that many state failure-to-warn claims against generic manufacturers are preempted when federal law requires the generic label to match the brand-name label, leaving generic drug plaintiffs with a significantly narrower set of available claims than those who took the brand-name equivalent.
Medical devices face a different preemption analysis. Class III medical devices that receive FDA approval through the premarket approval process carry a specific preemption provision under the Medical Device Amendments at 21 U.S.C. § 360k(a), and the Supreme Court held in Riegel v. Medtronic that state law tort claims imposing requirements different from or in addition to FDA's device-specific requirements are preempted. A plaintiff injured by an FDA-approved Class III medical device faces a significantly narrower range of available claims than a plaintiff injured by a standard consumer product, which is why the specific regulatory classification of a medical device is one of the first analytical questions in medical device litigation.
The Consumer Product Safety Act at 15 U.S.C. § 2064(b) requires manufacturers, distributors, and retailers who obtain information that reasonably supports the conclusion that a product contains a defect that creates a substantial product hazard to immediately inform the Consumer Product Safety Commission, with CPSC guidance calling for reporting within 24 hours of obtaining that information. This reporting obligation creates a parallel liability track in product cases: a company that knew about a defect and failed to report it has not only violated the CPSA but has created documentary evidence that it knew the product was dangerous and continued distributing it. Internal safety reports, engineering analyses, customer complaint records, and prior incidents involving the same defect that pre-date the injury are the documents plaintiff's counsel seeks first in product liability discovery, and CPSA reporting failures documented in those records frequently support punitive damages claims that can multiply the compensatory award significantly.
3. What Damages Product Liability Claims Produce and How Mass Tort Litigation Handles Cases at Scale
Product liability damages follow the same general tort framework as other personal injury claims, but the specific categories available depend on the nature of the injury and the manufacturer's conduct.
Economic damages include all medical expenses incurred for treatment of the product-related injury, from emergency care through surgery, rehabilitation, and ongoing treatment; all lost wages during the period the injury prevented the plaintiff from working; and the present value of reduced earning capacity when the injury causes permanent limitations. For serious injuries including permanent disability, traumatic brain injury, and conditions requiring long-term care, the economic damages from a single plaintiff can reach seven figures before non-economic damages are added. Non-economic damages for pain and suffering, loss of enjoyment of life, and disfigurement are separately evaluated and can significantly exceed the economic damage component in cases involving severe or permanent injury.
Punitive damages are available in product liability cases when the manufacturer's conduct was malicious, oppressive, or recklessly indifferent to consumer safety. The standard is most commonly met in cases where the manufacturer knew about the defect from internal testing or prior incidents, concealed that knowledge from consumers and regulators, and continued to sell the product rather than recalling or redesigning it. Punitive damages in product liability cases have produced some of the largest jury verdicts in American litigation history, and the threat of punitive exposure is what drives significant pre-trial settlement in cases where the plaintiff can establish prior knowledge. Defective product and product injury cases involving concealed prior knowledge require aggressive early discovery to establish the timeline between when the manufacturer first knew about the risk and when it acted.
How Multi-District Litigation Handles Product Liability Cases Involving Thousands of Plaintiffs
When a single defective product injures thousands of people, the cases are too numerous and geographically dispersed to litigate efficiently in isolation. Multi-district litigation under 28 U.S.C. § 1407 provides the procedural mechanism for coordinating them before a single federal judge.
MDL is not the same as a class action. Each plaintiff retains an individual claim, but common discovery, expert challenges, and bellwether trials are coordinated before one federal judge, producing efficiency that a separate case in each plaintiff's home district cannot match. The MDL process allows plaintiffs' counsel to develop the common factual record, including expert testimony on defect and causation and documentary evidence about the manufacturer's knowledge, once rather than thousands of times in separate courts. Bellwether trials, where a small number of representative cases go to trial to establish the likely range of verdicts for the broader pool, provide data that drives settlement negotiations for the remaining cases.
Many MDLs resolve through global settlement programs, where eligible claimants submit proof of injury and exposure under agreed criteria established by the settlement. Whether a plaintiff should participate in a settlement program or continue to trial individually depends on the strength and value of the specific claim and the settlement program's allocation methodology. A plaintiff with a particularly severe injury, strong causation evidence, or a prior knowledge case against the manufacturer may recover more through individual litigation than through a settlement fund that averages outcomes across a large claimant pool. Mass torts and multi-district litigation representation requires evaluating that trade-off before any settlement participation decision is made.
4. Frequently Asked Questions about Product Liability
Product liability questions arrive from people injured by a product they purchased and want to know whether the manufacturer can be held responsible even if the product came with a warning label, from families who lost a loved one and want to understand whether concealment of a known defect changes the damages available, from people injured by a pharmaceutical drug whose side effects were not disclosed, and from people who received notice of a mass tort settlement program and want to understand whether participating makes sense for their specific injury. Those situations generate the following answers.
What Is Product Liability and How Does It Differ from Negligence?
Product liability is a legal framework that allows injured consumers to hold manufacturers, distributors, and retailers responsible for injuries caused by defective products. The critical distinction from ordinary negligence is that most states apply strict liability to product defect claims under Restatement § 402A, meaning the plaintiff does not need to prove the manufacturer was careless. The plaintiff must show the product was defective in its manufacture, design, or warnings, and that the defect caused the injury. The manufacturer's use of reasonable care in the production process is not a defense to a strict liability claim, which is fundamentally different from how negligence works.
Who Can I Sue If I Was Injured by a Defective Product?
Under strict product liability, every member of the commercial supply chain who placed the product in the stream of commerce faces potential liability, including the finished product manufacturer, component part manufacturers, distributors, and retailers. The practical benefit is that there are multiple solvent defendants to pursue even when one manufacturer is bankrupt, foreign, or judgment-proof. For pharmaceutical drugs, the manufacturer is the primary target, but generic drug manufacturers face additional preemption defenses after PLIVA v. Mensing. For FDA-approved Class III medical devices, preemption under Riegel v. Medtronic significantly narrows the available claims against the device manufacturer.
What Are the Three Types of Product Defects and Which One Applies to My Case?
A manufacturing defect means the specific product that injured you deviated from its intended design: the factory error affected your unit but not necessarily others of the same model. A design defect means the entire product line is unreasonably dangerous as designed, and every unit built to that design shares the same risk. A warning defect means the manufacturer failed to adequately communicate a known risk to the users who needed that information. Most serious product liability cases involve claims under more than one theory, and establishing which theories apply requires reviewing the product's design specifications, the manufacturer's internal safety records, and the warnings actually provided. Product liability standards also vary by state on design defect tests and other issues, so the applicable framework depends on where the case is filed.
What Damages Are Available in a Product Liability Case, and When Can I Get Punitive Damages?
Economic damages cover all medical expenses, lost wages, and lost earning capacity caused by the defective product. Non-economic damages cover pain and suffering, loss of enjoyment of life, and disfigurement. Punitive damages are available when the manufacturer's conduct was malicious, oppressive, or recklessly indifferent to consumer safety, most commonly when the plaintiff can show the manufacturer knew about the defect from internal testing or prior incidents, concealed that knowledge from consumers and regulators, and continued selling the product. Punitive damages in product liability cases can substantially exceed the compensatory award and are the primary driver of pre-trial settlement in cases involving documented prior knowledge of a defect.
02 Jul, 2025
